| abstract |
Disclosed are compounds of the formula: n n nor the pharmaceutically acceptable salts or solvates thereof, wherein: Ar 1 is a chlorophenyl group, Ar 2 is a dichlorophenyl group, R 1 is a —(CH 2 ) m —X—(CH 2 ) n —R 2 group, X is a —NH—, —O—, —C(O)— or —S(O) 2 — group, and R 2 is a substituted phenyl group. These compounds are CB1 receptor modulators. Also disclosed are methods of treating CB1 modulated diseases or conditions such as the metabolic syndrome. |